Iovance Biotherapeutics Inc (IOVA) returns
Iovance Biotherapeutics returns over 10 years
$1,000 invested in Iovance Biotherapeutics ten years ago was worth $1,357 at the close on October 30, 2026, with dividends reinvested: an average return of 3.1% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -42.8% | — | $572.20 | -0.9% |
| 3 months | +80.8% | — | $1,808 | +2.1% |
| Year to date | +210.6% | — | $3,106 | +11.7% |
| 1 year | +334.9% | — | $4,349 | +12.4% |
| 3 years | +129.2% | +31.8% | $2,292 | +88.5% |
| 5 years | -65.1% | -19.0% | $348.83 | +76.0% |
| 10 years | +35.7% | +3.1% | $1,357 | +316.6% |
Iovance Biotherapeutics return by calendar year
| Year | IOVA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +210.6% | +11.7% | +198.9% |
| 2025 | -63.1% | +17.7% | -80.8% |
| 2024 | -9.0% | +24.9% | -33.9% |
| 2023 | +27.2% | +26.2% | +1.0% |
| 2022 | -66.5% | -18.2% | -48.4% |
| 2021 | -58.9% | +28.7% | -87.6% |
| 2020 | +67.6% | +18.4% | +49.3% |
| 2019 | +212.8% | +31.2% | +181.5% |
| 2018 | +10.6% | -4.6% | +15.2% |
| 2017 | +15.1% | +21.7% | -6.6% |
| 2016 | -10.0% | +12.0% | -22.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: IOVA financials
No forecast, no recommendation. This page describes Iovance Biotherapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.